New Target for Uveitis Therapy
Could targeting cGAS-STING represent a new treatment avenue for uveitis?
-
1
Uveitis is a major cause of vision loss, contributing to 15% of blindness in developed countries.
-
2
Current treatments like corticosteroids have limitations, especially in refractory uveitis cases.
-
3
The cGAS–STING pathway is identified as a potential new target for uveitis therapy.
-
4
Research using a mouse model showed that cGAS activation leads to increased ocular inflammation.
-
5
Targeting cGAS could provide a novel treatment strategy for patients unresponsive to existing therapies.